• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Monitoring HIV Drug Resistance: Early Warning Indicators to Assess Performance of Thailand's Antiretroviral Treatment Program.监测艾滋病毒耐药性:评估泰国抗逆转录病毒治疗项目绩效的早期预警指标
J Med Assoc Thai. 2017 Sep;100(9):944-952.
2
Assessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia.纳米比亚主要和分散式外展抗逆转录病毒治疗点的世界卫生组织艾滋病毒耐药性早期预警指标评估
PLoS One. 2016 Dec 1;11(12):e0166649. doi: 10.1371/journal.pone.0166649. eCollection 2016.
3
Population-based monitoring of HIV drug resistance early warning indicators in Uganda: A nationally representative survey following revised WHO recommendations.乌干达基于人群的 HIV 耐药性早期预警指标监测:根据世卫组织修订建议进行的全国代表性调查。
PLoS One. 2020 Apr 14;15(4):e0230451. doi: 10.1371/journal.pone.0230451. eCollection 2020.
4
HIV drug resistance early warning indicators in namibia with updated World Health Organization guidance.纳米比亚的艾滋病毒耐药性早期预警指标及世界卫生组织的最新指南
PLoS One. 2014 Jul 2;9(7):e100539. doi: 10.1371/journal.pone.0100539. eCollection 2014.
5
Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations.喀麦隆艾滋病毒耐药性早期预警指标监测:一项遵循世界卫生组织修订建议的研究
PLoS One. 2015 Jun 17;10(6):e0129210. doi: 10.1371/journal.pone.0129210. eCollection 2015.
6
Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon.喀麦隆中部地区城乡环境下青少年艾滋病毒耐药性的项目质量指标
AIDS Res Ther. 2020 May 12;17(1):14. doi: 10.1186/s12981-020-00270-7.
7
HIV drug-resistance early-warning indicators and quality care in India: preliminary findings from a pilot study in Pune city.印度的艾滋病毒耐药性早期预警指标与优质护理:浦那市一项试点研究的初步结果
WHO South East Asia J Public Health. 2015 Jul-Dec;4(2):123-129. doi: 10.4103/2224-3151.206681.
8
Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008-2010: lessons and challenges for low-resource settings.2008-2010 年喀麦隆 HIV 耐药性早期预警指标呈下降趋势:对资源匮乏环境的经验教训和挑战。
BMC Public Health. 2013 Apr 8;13:308. doi: 10.1186/1471-2458-13-308.
9
Early warning indicators for HIV drug resistance in Cameroon during the year 2010.2010 年期间喀麦隆的 HIV 耐药性早期预警指标。
PLoS One. 2012;7(5):e36777. doi: 10.1371/journal.pone.0036777. Epub 2012 May 17.
10
Population-based monitoring of HIV drug resistance in Namibia with early warning indicators.纳米比亚基于人群的 HIV 耐药性监测及早期预警指标。
J Acquir Immune Defic Syndr. 2010 Dec;55(4):27-31. doi: 10.1097/QAI.0b013e3181f5376d.

引用本文的文献

1
Treatment outcome of the implementation of HIV test and treat policy at The AIDs Support Organization (TASO) Tororo clinic, Eastern Uganda: A retrospective cohort study.乌干达东部托罗罗 TASO 诊所实施 HIV 检测和治疗政策的治疗结果:一项回顾性队列研究。
PLoS One. 2020 Sep 22;15(9):e0239087. doi: 10.1371/journal.pone.0239087. eCollection 2020.
2
Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon.喀麦隆中部地区城乡环境下青少年艾滋病毒耐药性的项目质量指标
AIDS Res Ther. 2020 May 12;17(1):14. doi: 10.1186/s12981-020-00270-7.

本文引用的文献

1
HIV-1 drug resistance-associated mutations among antiretroviral-naive Thai patients with chronic HIV-1 infection.慢性 HIV-1 感染的泰国初治患者中与抗逆转录病毒药物耐药相关的突变。
J Med Virol. 2013 Feb;85(2):194-9. doi: 10.1002/jmv.23452. Epub 2012 Nov 14.
2
Early warning indicators for HIV drug resistance in Cameroon during the year 2010.2010 年期间喀麦隆的 HIV 耐药性早期预警指标。
PLoS One. 2012;7(5):e36777. doi: 10.1371/journal.pone.0036777. Epub 2012 May 17.
3
Combining cohort analysis and monitoring of HIV early-warning indicators of drug resistance to assess antiretroviral therapy services in Vietnam.结合队列分析和监测 HIV 耐药预警指标评估越南的抗逆转录病毒治疗服务。
Clin Infect Dis. 2012 May;54 Suppl 4:S306-12. doi: 10.1093/cid/cir1045.
4
Monitoring HIV drug resistance using early warning indicators in China: results from a pilot survey conducted in 2008.利用早期预警指标监测中国的 HIV 耐药性:2008 年试点调查结果。
Clin Infect Dis. 2012 May;54 Suppl 4:S300-2. doi: 10.1093/cid/cir1018.
5
Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011.世界卫生组织 HIV 耐药性预防和评估策略更新:2004-2011 年。
Clin Infect Dis. 2012 May;54 Suppl 4(Suppl 4):S245-9. doi: 10.1093/cid/cis206.
6
Emergence of HIV-1 drug resistance mutations among antiretroviral-naïve HIV-1-infected patients after rapid scaling up of antiretroviral therapy in Thailand.在泰国迅速扩大抗逆转录病毒治疗后,抗逆转录病毒治疗初治的 HIV-1 感染者中出现了 HIV-1 耐药突变。
J Int AIDS Soc. 2012 Mar 12;15(1):12. doi: 10.1186/1758-2652-15-12.
7
National expansion of antiretroviral treatment in Thailand, 2000-2007: program scale-up and patient outcomes.2000 - 2007年泰国抗逆转录病毒治疗的全国性推广:项目扩大与患者治疗结果
J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):506-12. doi: 10.1097/QAI.0b013e3181967602.
8
The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.世界卫生组织预防和评估艾滋病毒耐药性的全球战略。
Antivir Ther. 2008;13 Suppl 2:1-13.
9
Antiretroviral drug resistance among antiretroviral-naïve persons with recent HIV infection in Thailand.泰国近期感染艾滋病毒且未接受过抗逆转录病毒治疗的人群中的抗逆转录病毒药物耐药性。
HIV Med. 2008 May;9(5):322-5. doi: 10.1111/j.1468-1293.2008.00562.x.
10
Genotypic resistance mutations in treatment-naïve and treatment-experienced patients under widespread use of antiretroviral drugs in Thailand: implications for further epidemiologic surveillance.在泰国广泛使用抗逆转录病毒药物的初治和经治患者中的基因型耐药突变:对进一步流行病学监测的意义
Jpn J Infect Dis. 2007 Sep;60(5):284-9.

监测艾滋病毒耐药性:评估泰国抗逆转录病毒治疗项目绩效的早期预警指标

Monitoring HIV Drug Resistance: Early Warning Indicators to Assess Performance of Thailand's Antiretroviral Treatment Program.

作者信息

Lertpiriyasuwat Cheewanan, Teeraratkul Achara, Suchonwanich Yolsilp, Chatharojwong Nartlada, Phokasawad Kunjanakorn, Yuktanon Porntip, Pattarapayoon Naparat, Bhakeecheep Sorakij, Bertagnolio Silvia, Roels Thierry H, Thanprasertsuk Sombat

机构信息

Bureau of AIDS, TB and STIs, Department of Disease Control, Thailand Ministry of Public Health, Nonthaburi, Thailand.

Thailand Ministry of Public Health-U.S. Centers for Disease Control and Prevention Collaboration, Division of Global HIV/AIDS and TB, Thailand/Asia Regional Office, Thailand.

出版信息

J Med Assoc Thai. 2017 Sep;100(9):944-952.

PMID:29861515
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5978419/
Abstract

OBJECTIVE

To describe trends in Thailand's antiretroviral treatment (ART) program performance assessed by HIV drug resistance early warning indicators (EWIs), as recommended by WHO, between 2009 and 2013.

MATERIAL AND METHOD

Seven EWIs were monitored, viral load (VL) testing coverage, VL suppression, retention in ART, lost to follow-up (LTFU), antiretrovirals (ARVs) dispensing practices, on-time pill pick-up, and pharmacy stock-outs. Data from ART adult patients in National Health Security Office Scheme were analyzed except for pharmacy stock-outs, which were reported from hospitals. Aggregated averages were calculated for each EWI. Chi-square for trend was applied to measure significant changes.

RESULTS

By September 2013, 174,284 adults were receiving ART at 929 hospitals. Over time, improvement in VL testing coverage (53.8% in 2009 to 79.8% in 2013) was observed. VL suppression and on-time pill pick up rates were well above 90%. Rates of retention in ART declined from 84.0 to 82.9%, whereas LTFU rates increased from 8.3 to 9.2% (p<0.001). Prescriptions with inappropriate ARVs decreased from 0.32 to 0.10% (p<0.001). Of reporting hospitals, 96.1%, 96.3%, and 96.2% observed no ARVs stock-out between 2011 and 2013.

CONCLUSION

EWI is a useful tool to monitor ART program performance and to identify area where improvement is needed.

摘要

目的

按照世界卫生组织的建议,描述2009年至2013年间泰国通过艾滋病毒耐药性早期预警指标(EWIs)评估的抗逆转录病毒治疗(ART)项目的执行趋势。

材料与方法

监测了七个早期预警指标,即病毒载量(VL)检测覆盖率、VL抑制率、ART治疗留存率、失访(LTFU)率、抗逆转录病毒药物(ARVs)发放情况、按时取药情况以及药房药品缺货情况。分析了国家卫生安全办公室计划中ART成年患者的数据,但药房药品缺货情况数据来自医院报告。计算每个早期预警指标的汇总平均值。应用趋势卡方检验来衡量显著变化。

结果

截至2013年9月,929家医院的174,284名成年人正在接受ART治疗。随着时间推移,观察到VL检测覆盖率有所提高(从2009年的53.8%提高到2013年的79.8%)。VL抑制率和按时取药率均远高于90%。ART治疗留存率从84.0%降至82.9%,而失访率从8.3%升至9.2%(p<0.001)。使用不适当ARVs的处方从0.32%降至0.10%(p<0.001)。在报告的医院中,96.1%、96.3%和96.2%在2011年至2013年间未出现ARVs缺货情况。

结论

早期预警指标是监测ART项目执行情况以及识别需要改进领域的有用工具。